RHODA MWANGI: Open Payments
NPI 1962115709 · GERMANTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 23 payments from 4 companies in 2025. Trend: 2023 $234 · 2024 $691 · 2025 $903
Food & beverage: $792Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $440 |
| Neurocrine BioSciences, Inc. | 14 | $205 |
| Janssen Pharmaceuticals, Inc | 2 | $137 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
Products named: UZEDY, INGREZZA, INVEGA SUSTENNA, COBENFY, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
